14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
OHI vs CTRE: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
OHI Wins Head-to-Head Institutional Verdict (3–3 across 6 Pillars · 6–4 Matrix Metrics)
OHI Overall Winner
6-Pillar Tally: OHI 3 – 3 CTRE
Matrix Metrics: OHI 6 – 4 CTRE
As of Nov 16, 2026, Omega Healthcare Investors Inc. (OHI) is the stronger overall head-to-head candidate over CareTrust REIT, Inc (CTRE) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Profitability & Quality, Options & Positioning, R&D & Supply-Chain Moat). OHI carries a Unified Composite Score of 50.5/100 (HOLD) at $46.91 (22.6x Forward P/E, 62.6% operating margin), whereas CTRE carries 49.0/100 (HOLD) at $37.66 (22.3x Forward P/E, 66.2% operating margin).
Growth vs. Quality Trade-Off: OHI earns the overall head-to-head edge with a stronger Unified Composite Score (50.5/100 HOLD vs. CTRE 49.0/100 HOLD) and -0.04β · 29% Vol risk profile, whereas CTRE leads top-line expansion (+33.2% YoY revenue growth, 1.26x PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates.
Technical & Structure Timing Caution: OHI is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 49.6); meanwhile CTRE trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 53.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Competes within the REIT - Healthcare Facilities value chain with $15.0B market capitalization and 62.6% operating margin.
OpEx & R&D Reinvestment33.2% of Rev ($418M)
90D Engineering Disclosures0 Published
CTRE Moat ProfileHigh-Margin Pricing Power Moat
REIT - Healthcare Facilities Operator
Competes within the REIT - Healthcare Facilities value chain with $9.8B market capitalization and 66.2% operating margin.
OpEx & R&D Reinvestment29.5% of Rev ($182M)
90D Engineering Disclosures0 Published
Investor FAQ OHI vs CTRE Key Questions & Quantitative Answers
As of Nov 16, 2026, Omega Healthcare Investors Inc. (OHI) is the stronger overall head-to-head candidate over CareTrust REIT, Inc (CTRE) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Profitability & Quality, Options & Positioning, R&D & Supply-Chain Moat). OHI carries a Unified Composite Score of 50.5/100 (HOLD) at $46.91 (22.6x Forward P/E, 62.6% operating margin), whereas CTRE carries 49.0/100 (HOLD) at $37.66 (22.3x Forward P/E, 66.2% operating margin). Growth vs. Quality Trade-Off: OHI earns the overall head-to-head edge with a stronger Unified Composite Score (50.5/100 HOLD vs. CTRE 49.0/100 HOLD) and -0.04β · 29% Vol risk profile, whereas CTRE leads top-line expansion (+33.2% YoY revenue growth, 1.26x PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: OHI is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 49.6); meanwhile CTRE trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 53.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
CTRE leads the Growth & Scale pillar: OHI posts -0.6% YoY revenue growth and -55.4% YoY earnings growth on $1.26B TTM revenue (95.8% gross margin, 62.6% operating margin), compared with CTRE at +33.2% YoY revenue growth and -0.8% YoY earnings growth on $615M TTM revenue (95.7% gross margin, 66.2% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), OHI cumulative revenue shifted +35.2% while CTRE shifted N/A. In operating R&D and SG&A reinvestment, OHI deploys 33.2% of Rev ($418M) (0 90-day corporate R&D disclosures) versus 29.5% of Rev ($182M) (0 disclosures) for CTRE.
CTRE screens cheaper on headline valuation multiples. OHI trades at 22.6x Forward P/E, 19.0x Trailing P/E, 11.99x PEG, and 14.9x EV/Revenue (67.9% FCF margin), whereas CTRE trades at 22.3x Forward P/E, 24.0x Trailing P/E, 1.26x PEG, and 18.6x EV/Revenue (78.8% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against OHI (14.5% ROE) versus CTRE (7.7% ROE) capital efficiency.
In options market volatility and institutional positioning, OHI carries 26.9% implied volatility (65th %ile, Elevated (60th–80th %ile)), a 0.71x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (-0.04β · 29% Vol realized risk). By comparison, CTRE carries 24.7% implied volatility (10th %ile, Compressed (<25th %ile)), a 6.12x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.14β · 28% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.